Sunrise, FL, Nov. 07, 2017 -- MDLIVE, a leading virtual medical and behavioral healthcare provider, today announced that consumers can access virtual dermatology services 24 hours a day, seven days a week via the MDLIVE platform. This service is available for self-paying consumers immediately and for health plans and employers with a 1/1/2018 effective date.
|
|||
Virtual dermatology consultations help address the sector’s increasing demand for timely access to care due to a dermatologist shortage. The average wait time to see a dermatologist in 15 major U.S. markets is more than 32 days1 with less than four dermatologists per 100,000 people2. The exclusive partnership with leading online dermatology provider, Iagnosis, gives consumers the opportunity to conduct full consultations, inclusive of a diagnosis, personalized treatment and appropriate prescriptions.
Once registered with MDLIVE, a consumer can choose dermatology from the options on the platform’s patient dashboard and will be taken directly to the partner site powered by Iagnosis. They are asked to provide a brief medical history, describe their condition, and send a few photos of the affected area of their skin, nails or hair. In an average of 18 hours, consumers are notified of a diagnosis and provided a treatment plan, which includes prescriptions if necessary.
“Access is one of the top issues consumers face when needing to see a dermatologist today,” said Dave Zynn, CEO of Iagnosis. “Wait times in some areas of the U.S. can be as long as three to six months. Now MDLIVE can reduce the patient’s wait time to get the dermatology specialty care they need from weeks or months to less than 24 hours. It’s also a great option for individuals suffering from chronic skin conditions who need to consult with a dermatologist on a regular basis. They don’t have to take time off work or take the kids out of school to get help with sudden flare-ups or to get their prescriptions refilled, and for routine follow-up.”
The Iagnosis network of board-certified dermatologists are trained to diagnose and treat more than 3,000 medical conditions affecting the skin, hair, and nails, including management of chronic skin conditions, such as acne, rosacea, psoriasis and eczema. In addition, dermatologists can conduct “spot checks” for individuals concerned about suspicious spots or moles on their skin. Iagnosis has a proven track record of success with patients, achieving a 98 percent satisfaction rate.
“By offering dermatological care virtually, we can better address the specialty’s access issue and serve consumers who often wait months for an appointment,” said Scott Decker, chief executive officer of MDLIVE. “At MDLIVE, we continue to evaluate our services and identify additional specialty offerings that meet consumers’ needs and demands, improving the health and outcomes of these individuals.”
For more information, visit MDLIVE.com/dermatology.
About MDLIVE
Founded in 2009, MDLIVE is a visionary and pioneer in the digital delivery of high-quality, convenient, cost-efficient virtual care for medical and behavioral health conditions. The company provides consumers, health plans, health systems and self-insured employers with 24/7/365 access to its network of board-certified doctors and licensed therapists via secure online video, and phone through the MDLIVE service and technology platform. Registered users can receive a virtual consultation through the company’s HIPAA and PHI-compliant secure, cloud-based platform from home or on the go. To learn more about how MDLIVE is using telehealth innovations to improve the delivery of healthcare, visit www.MDLIVE.com.
About Iagnosis
Iagnosis, Inc. is focused on delivering faster healthcare treatment to patients through web-enabled solutions. Its flagship dermatology product is best-in-class for helping board-certified dermatologists in the U.S. offer patients convenient 24/7 online and mobile access to affordable, high-quality skin, hair and nail medical care. Iagnosis has been recognized in the industry for its innovation and high patient satisfaction ratings, and the company actively partners with physician practices, health systems, retailers, and other organizations to provide comprehensive and personalized care solutions to patients.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/6b173f36-028b-43de-8ccd-9b25727fce67
Bethany Parker MDLIVE 615-577-1131 [email protected]


U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
Converse Cuts Corporate Jobs as Nike Restructures to Revive Sales Growth
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
Westpac (ASX: WBC) Q1 Profit Rises 6% as Lending Growth and Treasury Income Strengthen Earnings
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
How Marco Pharma International Preserves German Homeopathic Traditions in America
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes 



